1. Arenberger P., Arenbergerova M., Gkalpakiotis S., Lippert J., Stribrna J., Kremen J. 2008. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: A novel possible staging method. J. Eur. Acad. Dermatol. Venereol. 22, 56–64.
2. Johnson T.M., Smith J.W., 2nd, Nelson B.R., Chang A. 1995. Current therapy for cutaneous melanoma. J. Am. Acad. Dermatol. 32, 689–709.
3. Prehn R.T. 1996. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma. Cancer Res. 56, 937–940.
4. Wildemore J.K., Schuchter L., Mick R., Synnestvedt M., Elenitsas R., Bedrosian I., Czerniecki B.J., Guerry D., Lessin S.R., Elder D.E., Bucky L.P. 2001. Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study. Ann. Plast. Surg. 46, 488–494.
5. Vujanovic L., Butterfield L.H. 2007. Melanoma cancer vaccines and anti-tumor T cell responses. J. Cell. Biochem. 102, 301–310.